Sensient Technologies
SXT
132.00
-0.91
-0.68%
Sensient Technologies
US · SXT
#2027 by market cap
Listed 1970
132.00
-0.91
-0.68%
Live - 5344 symbols - heartbeat 480s ago
· 2026-10-07 19:54
After-hours
132.00
0.00%
- Market cap
- 5.62B
- P/E (TTM)i
- 35.58
- P/Bi
- 4.46
- EPSi
- 3.16
- Div yieldi
- 1.24%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on SXT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.6 percentage points.
Institutional ownership
- Held by institutions
- 100.37% -0.61pp
- Institutions
- 433 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund84.09%
Hedge Fund11.29%
Public Company1.87%
Individual/Insider1.62%
Sovereign Wealth Fund1.17%
Government Pension Fund1.15%
Private Company0.35%
Insurance Company0.34%
Top holders as of 2026-06-30
BlackRock
15.60% · 6.64M sh
Vanguard Portfolio Management, LLC
6.52% · 2.78M sh
Vanguard Capital Management, LLC
5.22% · 2.22M sh
Freemont Capital Pte. Ltd.
4.82% · 2.05M sh
State Street Global Advisors
4.04% · 1.72M sh
Janus Henderson Group plc
4.03% · 1.71M sh
Geode Capital Management, LLC
2.61% · 1.11M sh
Dimensional Fund Advisors
2.49% · 1.06M sh
Vaughan Nelson Investment Management, L.P.
2.37% · 1.01M sh
Congress Asset Management Company, LLP
2.19% · 930.34K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Paul Manning | Chairman, CEO, President & Member of Scientific Advisory Committee | 0.66% |
| Stephen Rolfs | Senior Vice President | 0.32% |
| Michael Geraghty | President of Color Group | 0.11% |
| John Manning | Senior Vice President | 0.09% |
| Amy Jones | VP of Human Resources & Senior Counsel | 0.06% |
| Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | 0.06% |
| Deborah McKeithan-Gebhardt | Independent Director & Member of Scientific Advisory Committee | 0.05% |
| Essie Whitelaw | Director & Member of Scientific Advisory Committee | 0.04% |
| Tobin Tornehl | Chief Accounting Officer | 0.04% |
| Thierry Hoang | -- | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +279 | -- |
| 2026-09-29 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +42 | -- |
| 2026-08-04 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Open Market Disposition | -1,200 | $129.48 |
| 2026-06-30 | Chandrabhushan Singh | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-06-29 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +296 | -- |
| 2026-06-29 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Other Derivative Acquisition | +44 | -- |
| 2026-05-17 | Thierry Hoang | -- | Open Market Disposition | -400 | $115.19 |
| 2026-05-03 | Thierry Hoang | -- | Open Market Disposition | -439 | $114.15 |
| 2026-04-29 | Freemont Capital Pte. Ltd. | -- | Open Market Disposition | -2,127,566 | $109.69 |
| 2026-04-29 | Steve Morris | President, Flavors & Extracts Group | Open Market Disposition | -200 | $114.58 |
| 2026-04-22 | Essie Whitelaw | Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Essie Whitelaw | Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Joseph Carleone | Independent Lead Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Scott Morrison | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Donald Landry | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
| 2026-04-22 | Carol Jackson | Independent Director & Member of Scientific Advisory Committee | Other Acquisition | +1,119 | -- |
| 2026-04-22 | Mario Ferruzzi | Independent Director & Member of Scientific Advisory Committee | Sale to Issuer | -674 | $99.23 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.